Patent intelligence · US
US 10788490
Dried cellulose-treated tissue for in-vitro complement activation assays and diagnostic kits
Dried cellulose-treated tissue for in-vitro complement activation assays and diagnostic kits
Patent details — US 10788490
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 29, 2020
- Expiration
- Sep 24, 2040
- Claims
- 18
- CPC classes
- A61K, A61K35/12
Quick answer
US 10788490 (Dried cellulose-treated tissue for in-vitro complement activation assays and diagnostic kits) is held by ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC.. Status: granted. Granted Sep 29, 2020. Expires Sep 24, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 18
- CPC classes
- A61K, A61K35/12
More from ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC.
Related pharmaceutical patents in our USPTO index.
-
US 12419888
Methods of treating elevated plasma cholesterol
granted -
US 11844771
Methods of treating acute respiratory distress syndrome using colchicine
granted -
US 11795434
Engineered stem cells and cellular products produced and secreted by such cells, methods of preparing, and uses thereof
granted -
US 11639490
Device and method for producing and purifying exosomes
granted -
US 11529390
PCSK9 inhibitory polypolypeptides and methods of use
granted -
US 11400063
Early administration of low-dose colchicine after myocardial infarction
granted -
US 9789134
Agent for the selective adjustment of blood lipids
granted
Frequently asked questions
What is US patent 10788490?
US 10788490 (Dried cellulose-treated tissue for in-vitro complement activation assays and diagnostic kits) is held by ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC.. Status: granted. Granted Sep 29, 2020. Expires Sep 24, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10788490?
ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 15 pharmaceutical patents for this assignee.
When does US 10788490 expire?
Our index shows an expiration date of Sep 24, 2040 (14 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.